Head to head
the arrow points to the better figure| Aster | Injective | |
|---|---|---|
| Trading | ||
| $8.02 | BTC trade, $10k | — |
| $1,124 | BTC trade, $1M | — |
| $39.6M | BTC book depth | — |
| 0.040%/0.000% | Taker / maker▶ | 0.000%/0.000% |
| 300x | ◀Max leverage | 100x |
| Size | ||
| $2.25B | ◀Volume 24h | $34.1M |
| $1.68B | ◀Volume, 7-day average | $48.7M |
| $1.37Bone side | Open interest | $3.3Mlongs + shorts |
| $505.4M | TVL | — |
| Markets | ||
| 599 | ◀Markets | 297 |
| 146 | ◀Stocks & RWA | 123 |
| 1h or 4h or 8h | Funding paid every | — |
| +0.0100% | BTC funding /8h | −0.0025% |
| +0.575% | BTC longs paid, 30d | +1.261% |
| Access | ||
| No ID | KYC | No ID |
| $ASTER | Token | $INJ |
| Stage 5 | Airdrop | — |
Volume by asset class
last 90 daysOn both: 0
funding /8h · Net 7d at $10kOnly on Aster: 569
BTC · ETH · SOL · ASTER · XAU · XRP · XAG · CL · MU · SPCX · WLFI · SNDK · SKHYNIX · SOXL · ZEC · LIT · HYPE · KITE · BNB · GPRO · BZ · BULLA · DOGE · META · PREDICT · KORU · NEAR · SYN · IDOL · AVAX · INTC · AGT · CAKE · ACN · TAO · MOONSHOT · AIN · BNC · OURA · QQQ · LTC · EVAA · BIANRENSHENG · SQQQ · CRCL · NVDA · LYN · SUI · PAXG · LINK · JCT · ATOM · OPENAI · XMR · LUMIA · STRC · BAT · DOT · WLD · MSTR · and 509 more
Only on Injective: 0
Questions
Which has more markets, Aster or Injective?
Aster lists 599 active markets and Injective 297; 0 assets trade on both.
Does Aster or Injective require KYC?
Aster: No ID to trade (the terms keep a right to limited checks); not for the US, Canada, the UK, China, Russia, Ukraine or sanctioned countries. Injective: No ID on Helix (email, Google or a wallet); Injective's terms block the UK, Canada, Russia, Belarus and sanctioned countries.
Can you arbitrage funding between Aster and Injective?
Not profitably right now: none of the 0 assets on both paid more in funding over the last 7 days than a round trip on both costs.
Which is bigger, Aster or Injective?
24-hour volume: Aster $2.25B, Injective $34.1M. Open interest as each reports it: $1.37B and $3.3M. Injective reports open interest as longs plus shorts, both sides of every position; Aster reports one side. For the same positions Injective's figure reads about twice as large. TVL: $505.4M and none published.